TuHURA Biosciences (HURA) Current Leases (2023 - 2026)
TuHURA Biosciences' (HURA) quarterly Current Leases came in at $206851.0 in Q1 2026, up 25.67% year-on-year from $164594.0 in Q1 2025, and up 3.92% quarter-over-quarter from $199041.0 in Q4 2025.
TuHURA Biosciences (HURA) Current Leases (2023 - 2026) Analysis & Trends
TuHURA Biosciences' Current Leases history runs 4 years deep, the most recent figure standing at $206851.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 25.67% year-over-year to $206851.0 in Q1 2026; TTM through Mar 2026 was $206851.0, a 25.67% increase from a year earlier, with the FY2025 full-year figure at $199041.0, up 24.52% from the prior year.
- Current Leases rose to $206851.0 in Q1 2026 per HURA's latest filing, from $199041.0 in the prior quarter.
- Across five years, Current Leases topped out at $206851.0 in Q1 2026 and bottomed at $20820.0 in Q4 2023.
- The 4-year median for Current Leases is $159844.0 (2024), against an average of $137209.3.
- Across the five-year window, Current Leases soared 667.74% in 2024 and rose 24.52% in 2025, its largest moves.
- Year by year, Current Leases stood at $20820.0 in 2023, then surged by 667.74% to $159844.0 in 2024, then grew by 24.52% to $199041.0 in 2025, then rose by 3.92% to $206851.0 in 2026.
- Per Business Quant, the three latest HURA Current Leases figures stand at $206851.0 (Q1 2026), $199041.0 (Q4 2025), and $84346.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 11.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 16.61 Mn |
| 10 | TuHURA Biosciences | 132.62 Mn | 132.62 Mn | - | 206,851.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 206,851.00 |
| Dec 31, 2025 | 199,041.00 |
| Sep 30, 2025 | 84,346.00 |
| Jun 30, 2025 | 124,969.00 |
| Mar 31, 2025 | 164,594.00 |
| Dec 31, 2024 | 159,844.00 |
| Dec 31, 2023 | 20,820.00 |